Tricyclic erythromycin derivatives
US6274715A · kind A · utility
26Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 7, 1997 |
| Grant date | Aug 14, 2001 |
| Priority date | — |
| Expiry date | Jan 7, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H17/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds, or pharmaceutically acceptable salts and esters thereof, of the formula: ##STR1## wherein A, B, D and E, R.sup.1, R.sup.2, and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.